University of Colorado
Anschutz Medical Campus
Medical and Behavioral Health Programs
The educational design of this activity addresses the needs of healthcare professionals who care for people living with HIV, including MDs, NPs, PAs, nurses, pharmacists, case managers, peer educators, medical assistants, and office staff.
This enduring webinar aims to educate clinicians about the dangers of patients becoming lost to HIV care and strategies to re-engage them. Balancing existing data and clinic models with their own success stories, Drs. Kellie Hawkins and Stacey Trooskin present data on consequences of patients becoming lost to follow-up, identifying patients lost to follow-up, strategies to bring patients back into HIV care, and optimal ways to collaborate with community partners. Further, additional videos about hard-to-reach populations and the use of trauma-informed care are available on the landing page.
After completing this activity, the participant should be better able to:
- Discuss risk factors and strategies to identify people with HIV who are lost to follow-up
- Identify effective communication and educational tactics to improve re-engagement among people with HIV who have fallen out of care
- Collaborate with community organizations to improve re-engagement in care for people with HIV
- What Does Lost to Follow-up (LTFU) Mean in HIV: Definitions and Epidemiology
- How to Identify Patients with HIV Who Are LTFU
- Achieving Retention in Care and Viral Suppression: What Will Work for Your Clinic
Physician Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Continuing Education
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Integritas Communications. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 0.5 contact hour (which includes 0.0 hour(s) of pharmacology).
Global Contact Information
For information about the approval of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org.
Instructions to Receive Credit
To receive credit for this activity, participants must complete the preactivity questionnaire, complete and receive a minimum score of 70% on the posttest, and complete the program evaluation.
Fee Information & Refund /Cancellation Policy
There is no fee for this educational activity.
Disclosures of Relevant Financial Relationships
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Kellie Hawkins, MD: Nothing to disclose
Stacey B. Trooskin, MD, PhD, MPH: Consulting Fee: Theratechnologies; Contracted Research: Gilead Sciences, Inc.
The planners and managers at Global Education Group and Integritas Communications have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Integritas Communications do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.